Ductal carcinoma in situ (DCIS), accounting for 15-25% of all breast cancers, is frequently diagnosed by mammographic examination. This heterogeneous disease requires a rigorous local treatment based, in about two-third of cases, on conservative surgery and radiotherapy. DCIS are currently classified on the basis of nuclear grade. Most lesions, and especially high nuclear grade DCIS, are limited to one quadrant. Micropapillary DCIS are likely to be of larger size/extent and thus a conservative approach is often difficult. A careful pathological examination of an oriented excisional biopsy is a pre-requisite for optimal therapy
Ductal carcinoma in situ (DCIS), first termed intraductal, noninvasive, or noninfiltrating carcinoma...
Mammary ductal carcinoma in-situ (DCIS), a malignant appearing lesion on cytological and histologica...
Ductal carcinoma in situ (DCIS) of the breast is diagnosed more and more often in the Netherlands as...
AIM: The ductal carcinoma in situ (DCIS) is a more and more frequent neoplasia, representing over 2...
The frequency of diagnosis of ductal carcinoma in situ (DCIS) has increased in Australia, largely be...
The incidence of ductal carcinoma in situ (DCIS), a nonin-vasive form of breast cancer, has increase...
Ductal carcinoma in situ (DCIS) is a proliferation of presumably malignant epithelial cells within t...
Ductal carcinoma in situ (DCIS) is noninvasive breast cancer that encompasses a wide spectrum of dis...
Aim: The ductal carcinoma in situ is a malignant proliferation of mammary ductal epithelial cells wi...
Ductal carcinoma in situ (DCIS) is a biologically and morphologically heterogeneous disease. The inc...
Ductal carcinoma in situ (DCIS) is a heterogeneous, unicentric precursor of invasive breast cancer, ...
Several dilemmas exist when treating a patient with ductal carcinoma in situ (DCIS): the high rate o...
Ductal carcinoma in situ (DCIS) of the breast is a proliferative lesion, precursor of cancer, which ...
Aim. The ductal carcinoma in situ (DCIS) is a more and more frequent neoplasia, representing over 25...
Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detect...
Ductal carcinoma in situ (DCIS), first termed intraductal, noninvasive, or noninfiltrating carcinoma...
Mammary ductal carcinoma in-situ (DCIS), a malignant appearing lesion on cytological and histologica...
Ductal carcinoma in situ (DCIS) of the breast is diagnosed more and more often in the Netherlands as...
AIM: The ductal carcinoma in situ (DCIS) is a more and more frequent neoplasia, representing over 2...
The frequency of diagnosis of ductal carcinoma in situ (DCIS) has increased in Australia, largely be...
The incidence of ductal carcinoma in situ (DCIS), a nonin-vasive form of breast cancer, has increase...
Ductal carcinoma in situ (DCIS) is a proliferation of presumably malignant epithelial cells within t...
Ductal carcinoma in situ (DCIS) is noninvasive breast cancer that encompasses a wide spectrum of dis...
Aim: The ductal carcinoma in situ is a malignant proliferation of mammary ductal epithelial cells wi...
Ductal carcinoma in situ (DCIS) is a biologically and morphologically heterogeneous disease. The inc...
Ductal carcinoma in situ (DCIS) is a heterogeneous, unicentric precursor of invasive breast cancer, ...
Several dilemmas exist when treating a patient with ductal carcinoma in situ (DCIS): the high rate o...
Ductal carcinoma in situ (DCIS) of the breast is a proliferative lesion, precursor of cancer, which ...
Aim. The ductal carcinoma in situ (DCIS) is a more and more frequent neoplasia, representing over 25...
Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detect...
Ductal carcinoma in situ (DCIS), first termed intraductal, noninvasive, or noninfiltrating carcinoma...
Mammary ductal carcinoma in-situ (DCIS), a malignant appearing lesion on cytological and histologica...
Ductal carcinoma in situ (DCIS) of the breast is diagnosed more and more often in the Netherlands as...